Few U.S. Jails Offer Medications for Opioid Use Disorder
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Sept. 24, 2024 -- Few U.S. jails offer medications for opioid use disorder (MOUD), according to a study published online Sept. 24 in JAMA Network Open.
Elizabeth Flanagan Balawajder, M.P.H., from NORC at the University of Chicago, and colleagues examined the prevalence of MOUD in U.S. jails and the association of jail- and county-level factors with MOUD prevalence using a nationally representative cross-sectional survey querying 1,028 jails from June 2022 to April 2023 on their provision of substance use disorder treatment.
The researchers found that fewer than half of the jails (43.8 percent) offered MOUD to at least some individuals and only 12.8 percent of jails offered MOUD to anyone with an OUD. The likelihood of offering MOUD was higher for jails located in counties with lower social volume ability (adjusted odds ratio per 1-percentile increase in social vulnerability, 0.28) and shorter mean distances to the nearest facility providing MOUD (adjusted odds ratio per 1-standard deviation increase in mean drive time above the mean, 0.80).
"In this national survey study, relatively few jails indicated offering MOUD, the frontline treatment for OUD," the authors write. "Increasing resources for health care services in jails and expanding MOUD availability in communities are likely necessary first steps given that our data highlight the importance of the community context surrounding the jail."
Two authors disclosed involvement in expert witness work for opioid-related litigation.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-25 12:00
Read more
- Female Pediatricians Earn About 93 Percent of Male Pediatricians
- There's Been a Big Improvement in Lung Cancer Survival
- Short-Term Hormone Therapy for Menopause Won't Harm Women's Brains
- 2010 to 2021 Saw Rise in Postpartum Depression
- Abortion Rights Measures Pass in 7 States, Fail in 3
- ASH: Complications Common With Controlled Ovarian Hyperstimulation in Sickle Cell Anemia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions